SIMPSON CAMILLA V 4

4 · SPRUCE BIOSCIENCES, INC. · Filed May 21, 2021

Form 4

Period: 2021-05-20

Director

Transactions

Exercise/Conversion
Common Stock
2021-05-20$0.85/sh+334$284→ 334 total
Sale
Common Stock
2021-05-20$15.29/sh−334$5,107→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-05-20−334→ 1,673 total
Exercise: $0.85Exp: 2027-10-18→ Common Stock (2,007 underlying)
Award
Stock Option (Right to Buy)
2021-05-20+10,000→ 10,000 total
Exercise: $15.24Exp: 2031-05-19→ Common Stock (10,000 underlying)

Footnotes (3)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
[F2]The shares subject to the stock option vest over a four-year period commencing October 19, 2017, with 1/4th of the shares vesting on October 19, 2018 and 1/36th of the remaining shares vesting on a monthly basis.
[F3]The shares vest on the first anniversary of the Grant Date, provided that the Option will in any case be fully vested on the date of Company's 2022 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the 2020 Equity Incentive Plan (the "Plan")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan).

Documents

1 file